Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
23.33
-0.68 (-2.83%)
Jul 28, 2026, 1:47 PM EDT - Market open
Sutro Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 99.61 | 102.48 | 62.04 | 153.73 | 67.77 | 61.88 | |
Revenue Growth | 49.94% | 65.18% | -59.64% | 126.84% | 9.52% | 44.84% |
Gross Profit | 99.61 | 102.48 | 62.04 | 153.73 | 67.77 | 61.88 |
Selling, General & Admin | 35.33 | 41.02 | 48.45 | 62.58 | 59.54 | 56 |
Research & Development | 151.37 | 166.42 | 252.04 | 180.43 | 137.17 | 104.4 |
Other Operating Expenses | 32.41 | 53.42 | - | - | - | - |
Total Operating Expenses | 219.12 | 260.85 | 300.5 | 243.01 | 196.72 | 160.4 |
Operating Income | -119.51 | -158.37 | -238.45 | -89.28 | -128.94 | -98.52 |
Interest Income | 7.7 | 9.25 | 18.64 | 14.51 | 3.46 | 0.58 |
Interest Expense | -38.33 | -38.21 | -31.07 | -12.57 | - | - |
Other Non-Operating Income (Expense) | -3.57 | -3.86 | 25.78 | -1.26 | 8.78 | -7.59 |
Total Non-Operating Income (Expense) | -34.21 | -32.81 | 13.36 | 0.68 | 12.24 | -7.01 |
Pretax Income | -153.72 | -191.18 | -225.1 | -88.6 | -116.7 | -105.54 |
Provision for Income Taxes | -0.12 | -0.09 | 2.36 | 18.19 | 2.5 | - |
Net Income | -153.6 | -191.09 | -227.46 | -106.79 | -119.2 | -105.54 |
Net Income to Common | -153.6 | -191.09 | -227.46 | -106.79 | -119.2 | -105.54 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 10 | 8 | 8 | 6 | 5 | 5 |
Shares Outstanding (Diluted) | 10 | 8 | 8 | 6 | 5 | 5 |
Shares Change | 16.90% | 9.84% | 28.59% | 18.57% | 10.02% | 41.59% |
EPS (Basic) | -16.43 | -22.49 | -29.40 | -17.80 | -23.50 | -22.90 |
EPS (Diluted) | -16.43 | -22.49 | -29.40 | -17.80 | -23.50 | -22.90 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -152.14 | -178.93 | -194.64 | -115.93 | -4.31 | -97 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -15.70 | -21.06 | -25.16 | -19.27 | -0.85 | -21.03 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -119.98% | -154.53% | -384.33% | -58.07% | -190.26% | -159.22% |
Profit Margin | -154.21% | -186.45% | -366.62% | -69.47% | -175.89% | -170.55% |
FCF Margin | -152.74% | -174.59% | -313.72% | -75.41% | -6.36% | -156.76% |
EBITDA | -112.81 | -151.04 | -231.24 | -82.46 | -123.25 | -93.68 |
EBITDA Margin | -113.25% | -147.38% | -372.70% | -53.64% | -181.86% | -151.39% |
EBIT | -119.51 | -158.37 | -238.45 | -89.28 | -128.94 | -98.52 |
EBIT Margin | -119.98% | -154.53% | -384.33% | -58.07% | -190.26% | -159.22% |
Effective Tax Rate | 0.07% | 0.05% | -1.05% | -20.53% | -2.14% | 0.00% |